BBIO
Price
$34.85
Change
-$0.97 (-2.71%)
Updated
May 8 closing price
Capitalization
6.62B
83 days until earnings call
BEAM
Price
$17.25
Change
+$1.02 (+6.28%)
Updated
May 8 closing price
Capitalization
1.63B
95 days until earnings call
Ad is loading...

BBIO vs BEAM

Header iconBBIO vs BEAM Comparison
Open Charts BBIO vs BEAMBanner chart's image
BridgeBio Pharma
Price$34.85
Change-$0.97 (-2.71%)
Volume$5.32M
Capitalization6.62B
Beam Therapeutics
Price$17.25
Change+$1.02 (+6.28%)
Volume$3.15M
Capitalization1.63B
BBIO vs BEAM Comparison Chart
Loading...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BBIO vs. BEAM commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBIO is a StrongBuy and BEAM is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (BBIO: $34.85 vs. BEAM: $17.25)
Brand notoriety: BBIO and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBIO: 172% vs. BEAM: 119%
Market capitalization -- BBIO: $6.62B vs. BEAM: $1.63B
BBIO [@Biotechnology] is valued at $6.62B. BEAM’s [@Biotechnology] market capitalization is $1.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBIO’s FA Score shows that 1 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • BBIO’s FA Score: 1 green, 4 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BBIO is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBIO’s TA Score shows that 5 TA indicator(s) are bullish while BEAM’s TA Score has 4 bullish TA indicator(s).

  • BBIO’s TA Score: 5 bullish, 5 bearish.
  • BEAM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BBIO is a better buy in the short-term than BEAM.

Price Growth

BBIO (@Biotechnology) experienced а -9.24% price change this week, while BEAM (@Biotechnology) price change was -13.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

BBIO is expected to report earnings on Jul 31, 2025.

BEAM is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BBIO($6.62B) has a higher market cap than BEAM($1.63B). BBIO YTD gains are higher at: 27.004 vs. BEAM (-30.444). BEAM has higher annual earnings (EBITDA): -383.98M vs. BBIO (-436.83M). BEAM has more cash in the bank: 851M vs. BBIO (681M). BEAM has less debt than BBIO: BEAM (161M) vs BBIO (1.73B). BBIO has higher revenues than BEAM: BBIO (222M) vs BEAM (63.5M).
BBIOBEAMBBIO / BEAM
Capitalization6.62B1.63B405%
EBITDA-436.83M-383.98M114%
Gain YTD27.004-30.444-89%
P/E RatioN/AN/A-
Revenue222M63.5M350%
Total Cash681M851M80%
Total Debt1.73B161M1,075%
FUNDAMENTALS RATINGS
BBIO: Fundamental Ratings
BBIO
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
88
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBIOBEAM
RSI
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
72%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BLOK43.321.91
+4.61%
Amplify Transformational Data Shrg ETF
DTEC45.710.79
+1.76%
ALPS Disruptive Technologies ETF
MFM5.21N/A
N/A
MFS Municipal Income Trust
DIEM27.61-0.05
-0.17%
Franklin Emerging Mkt Core Div TltIdxETF
VWOB63.35-0.23
-0.36%
Vanguard Emerging Mkts Govt Bd ETF

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with ARGX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then ARGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
-2.71%
ARGX - BBIO
46%
Loosely correlated
-8.64%
AXON - BBIO
44%
Loosely correlated
+14.13%
ARRY - BBIO
43%
Loosely correlated
+9.13%
PMN - BBIO
43%
Loosely correlated
-10.63%
ROIV - BBIO
41%
Loosely correlated
-1.25%
More

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+6.32%
CRSP - BEAM
72%
Closely correlated
+5.52%
NTLA - BEAM
66%
Loosely correlated
+13.58%
RXRX - BEAM
63%
Loosely correlated
+4.77%
PRME - BEAM
59%
Loosely correlated
-7.04%
RCKT - BEAM
58%
Loosely correlated
+11.57%
More